DHR’s 6.6% Single Day Rise Brings Valuations Into Focus – Is A a Better Deal?

DHR: Danaher logo
DHR
Danaher

Agilent Technologies (A) offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Danaher (DHR), suggesting you may be better off investing in A

  • A’s quarterly revenue growth was 10.1%, vs. DHR’s 3.4%.
  • In addition, its Last 12 Months revenue growth came in at 4.5%, ahead of DHR’s 1.9%.
  • A’s LTM margin is higher: 21.3% vs. DHR’s 18.4%.

DHR designs and markets professional, medical, industrial products across Life Sciences, Diagnostics, and Environmental segments, offering advanced instruments and automation systems for research, diagnostics, and therapy. A provides life sciences and diagnostics solutions, including liquid chromatography, DNA mutation detection, genotyping, gene expression profiling, next-generation sequencing, and genetic data management.

Valuation & Performance Overview

  DHR A Preferred
     
Valuation      
P/EBIT Ratio 32.2 25.2 A
     
Revenue Growth      
Last Quarter 3.4% 10.1% A
Last 12 Months 1.9% 4.5% A
Last 3 Year Average -2.6% 0.8% A
     
Operating Margins      
Last 12 Months 18.4% 21.3% A
Last 3 Year Average 21.6% 21.5% DHR
     
Momentum      
Last 3 Year Return -12.3% 8.1% A

Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: DHR Revenue Comparison | A Revenue Comparison
See more margin details: DHR Operating Income Comparison | A Operating Income Comparison
 
But do these numbers tell the full story? Read Buy or Sell A Stock to see if Agilent Technologies’s edge holds up under the hood or if Danaher still has cards to play (see Buy or Sell DHR Stock).

Relevant Articles
  1. Stocks, Bonds, Gold, Crypto: Market Update 12/17/2025
  2. Sell Tesla Stock, Buy Rivian?
  3. How to Get Paid to Buy IT at a Steep Discount
  4. Short Apple Stock – Now?
  5. The Next Big Rally in UnitedHealth Stock Could Start Like This
  6. What Can Cause Pfizer Stock To Crash?

That is one way to look at stocks. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure

Historical Market Performance

  2020 2021 2022 2023 2024 2025 Total [1] Avg Best
Returns
DHR Return 45% 49% -19% -1% -0% -13% 39%  
A Return 40% 36% -6% -6% -3% -4% 50%  
S&P 500 Return 16% 27% -19% 24% 23% 14% 106% <===
Monthly Win Rates [3]
DHR Win Rate 67% 83% 33% 50% 42% 25%   50%  
A Win Rate 75% 83% 42% 42% 50% 50%   57%  
S&P 500 Win Rate 58% 75% 42% 67% 75% 62%   63% <===
Max Drawdowns [4]
DHR Max Drawdown -21% -4% -28% -21% -3% -24%   -17%  
A Max Drawdown -26% -3% -29% -32% -9% -26%   -21%  
S&P 500 Max Drawdown -31% -1% -25% -1% -2% -15%   -12% <===

[1] Cumulative total returns since the beginning of 2020
[2] 2025 data is for the year up to 9/30/2025 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year

 
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read A Dip Buyer Analyses to see how the stock has fallen and recovered in the past.